Literature DB >> 15951532

Insulin resistance and steatosis in hepatitis C virus infection.

A Zekry1, J G McHutchison, A M Diehl.   

Abstract

The relationship between hepatitis C virus (HCV), steatosis, and insulin resistance is genotype specific, and steatosis and insulin resistance are closely linked to the progression of liver disease in HCV infected patients.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15951532      PMCID： PMC1774605          DOI： 10.1136/gut.2004.059873

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  46 in total

1.  Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients.

Authors:  L E Adinolfi; R Utili; G Ruggiero
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

2.  Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.

Authors:  J M Petit; J B Bour; C Galland-Jos; A Minello; B Verges; M Guiguet; J M Brun; P Hillon
Journal:  J Hepatol       Date:  2001-08       Impact factor: 25.083

3.  Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus.

Authors:  Hervé Lerat; Masao Honda; Michael R Beard; Kim Loesch; Jiaren Sun; Yan Yang; Michiari Okuda; Rainer Gosert; Shu-Yuan Xiao; Steven A Weinman; Stanley M Lemon
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

4.  Weight gain as a risk factor for clinical diabetes mellitus in women.

Authors:  G A Colditz; W C Willett; A Rotnitzky; J E Manson
Journal:  Ann Intern Med       Date:  1995-04-01       Impact factor: 25.391

Review 5.  Histopathology of hepatitis C virus infection.

Authors:  Z D Goodman; K G Ishak
Journal:  Semin Liver Dis       Date:  1995-02       Impact factor: 6.115

6.  Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?

Authors:  Shivakumar Chitturi; Geoffrey Farrell; Linda Frost; Adamandia Kriketos; Rita Lin; Caroline Fung; Christopher Liddle; Dev Samarasinghe; Jacob George
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

7.  Overexpression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver.

Authors:  Jay D Horton; Iichiro Shimomura; Shinji Ikemoto; Yuriy Bashmakov; Robert E Hammer
Journal:  J Biol Chem       Date:  2003-07-10       Impact factor: 5.157

8.  Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo.

Authors:  Hiroshi Inoue; Wataru Ogawa; Michitaka Ozaki; Sanae Haga; Michihiro Matsumoto; Kensuke Furukawa; Naoko Hashimoto; Yoshiaki Kido; Toshiyuki Mori; Hiroshi Sakaue; Kiyoshi Teshigawara; Shiyu Jin; Haruhisa Iguchi; Ryuji Hiramatsu; Derek LeRoith; Kiyoshi Takeda; Shizuo Akira; Masato Kasuga
Journal:  Nat Med       Date:  2004-01-11       Impact factor: 53.440

9.  Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms.

Authors:  Kohjiro Ueki; Tatsuya Kondo; C Ronald Kahn
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

10.  Modulation of insulin activities by leptin.

Authors:  B Cohen; D Novick; M Rubinstein
Journal:  Science       Date:  1996-11-15       Impact factor: 47.728
View more
  12 in total

1.  Chemokine antagonism in chronic hepatitis C virus infection.

Authors:  Edgar D Charles; Lynn B Dustin
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

2.  Effect of Breathwalk on body composition, metabolic and mood state in chronic hepatitis C patients with insulin resistance syndrome.

Authors:  M Vázquez-Vandyck; S Roman; J L Vázquez; L Huacuja; G Khalsa; R Troyo-Sanromán; A Panduro
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

3.  Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial.

Authors:  Lucivalda P M Oliveira; Rosangela P de Jesus; Ramona S S B Boulhosa; Carlos Mauricio C Mendes; Maria Cecilia Gnoatto; Denise C Lemaire; Maria Betania P Toralles; Lourianne N Cavalcante; Andre C Lyra; Luiz G C Lyra
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

4.  Mechanisms of glucose intolerance in patients with chronic hepatitis C: implications for treatment.

Authors:  Pierre M Gholam; Angela F Domingo
Journal:  Curr Infect Dis Rep       Date:  2007-03       Impact factor: 3.725

Review 5.  A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease.

Authors:  P Riley; J O'Donohue; M Crook
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

6.  Treatment responses in Asians and Caucasians with chronic hepatitis C infection.

Authors:  Kenneth-K Yan; Marianne Guirgis; Thuy Dinh; Jacob George; Anouk Dev; Alice Lee; Amany Zekry
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

7.  Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.

Authors:  G Svegliati-Baroni; E Bugianesi; T Bouserhal; F Marini; F Ridolfi; F Tarsetti; F Ancarani; E Petrelli; E Peruzzi; M Lo Cascio; M Rizzetto; G Marchesini; A Benedetti
Journal:  Gut       Date:  2007-03-28       Impact factor: 23.059

8.  Topological and evolutional relationships between HCV core protein and hepatic lipid vesicles: studies in vitro and in conditionally transgenic mice.

Authors:  Ming-Ling Chang; Jeng-Chang Chen; Chau-Ting Yeh; I-Shyan Sheen; Dar-In Tai; Ming-Yu Chang; Cheng-Tang Chiu; Deng-Yn Lin; D Montgomery Bissell
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

Review 9.  Alcoholic liver disease and hepatitis C virus infection.

Authors:  Ignacio Novo-Veleiro; Lucía Alvela-Suárez; Antonio-Javier Chamorro; Rogelio González-Sarmiento; Francisco-Javier Laso; Miguel Marcos
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

10.  Metabolic syndrome in patients with chronic hepatitis C virus genotype 1 infection who do not have obesity or type 2 diabetes.

Authors:  Lucivalda Pereira Magalhães Oliveira; Rosangela P de Jesus; Ramona S S B Boulhosa; Carlos Mauricio C Mendes; Andre Castro Lyra; Luiz Guilherme C Lyra
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.